ロード中...

Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing

BACKGROUND. The efficacy of adjuvant targeted therapy for operable lung cancer is still under debate. Comprehensive genetic profiling is needed for detecting co‐mutations in resected epidermal growth factor receptor (EGFR)‐mutated lung adenocarcinoma (ADC), which may interfere the efficacy of adjuva...

詳細記述

保存先:
書誌詳細
出版年:Oncologist
主要な著者: Zhao, Ze‐Rui, Lin, Yao‐Bin, Ng, Calvin S.H., Zhang, Rong, Wu, Xue, Ou, Qiuxiang, Chen, Wendan, Zhou, Wen‐Jie, Lin, Yong‐Bin, Su, Xiao‐Dong, Shao, Yang W., Long, Hao
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley & Sons, Inc. 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795151/
https://ncbi.nlm.nih.gov/pubmed/30872465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0567
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!